12 July, Minsk /BELTA/. All social sphere facilities must be completed in Belarus in 2011, with the main funds invested in fast-recouping projects. This task was set on 9 July by the President of the country, Alexander Lukashenko, during a working trip to the Vitebsk region, the press service of the Belarusian leader informed a BELTA correspondent.

The Head of State visited the Vitebsk Biopharma, where he familiarised himself with the organisation of production of modern veterinary drugs, their supply to domestic and foreign markets, as well as with modern equipment and the technological process of veterinary drug production.

Vitebsk Biopharma is the only enterprise in the biological industry in the republic that manufactures medicinal serums and bacterial vaccines for the needs of animal husbandry. From 1995 to 2010, the production of over 60 types of veterinary drugs was mastered. The products manufactured by the biopharma are intended for the detection, prevention and successful treatment of the most common bacterial and viral infections in animal husbandry.

In 2005, the reconstruction of the biopharma began with the aim of creating proper sanitary and hygienic conditions, reorganising technological processes at a modern level, and also most fully satisfying the needs of the republic's animal husbandry in biological preparations. To complete the reconstruction, technological re-equipment, landscaping of the territory, and development of new types of products (viral drugs), additional funding from the republican budget in the amount of Br4.5 billion is required.

As reported to the Head of State, the enterprise is actively engaged in import substitution of veterinary medicines. It is planned that by 2015, 80% of such bioproducts will be produced in the country. The National Academy of Sciences of Belarus has developed 18 antiviral drugs and 14 bacterial drugs, which have been transferred to the biopharma. In addition, 50 technologies for new drugs, also developed by Belarusian scientists, are being worked out here. Alexander Lukashenko believes that today Vitebsk Biopharma can fully cover the country's needs for its products, as well as export part of them abroad.

The President set the task of increasing export capabilities not only for this enterprise but for all Belarusian enterprises as a whole.